Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery...

WHOOP, the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and longevity. Paired with a redesigned WHOOP experience, the devices offer 14-day battery life in a sleeker, seven percent smaller form - and introduce category-defining features, including Healthspan with WHOOP Age, Heart Screener with on-demand ECG, Blood Pressure Insights, and more. This press release features multimedia. View the...

Adtran today launched its Ensemble Cloudlet vRouter, a cloud-managed solution that enables providers to deliver high-performance Layer 3 managed services with less cost, complexity and risk. As traditional routers reach end-of-life and core network revenues remain flat, providers are looking to enterprise sites to drive new growth. Delivered through a single subscription, the new solution offers a lower-cost alternative to proprietary appliances while enabling smarter service delivery, faster r...

ITRS, the global leader in real-time monitoring and observability for mission-critical, highly regulated environments, announced the release of Distributed Tracing powered by OpenTelemetry (OTel). This industry-standard, open-source approach underpins powerful new capabilities within the ITRS Analytics platform, to give enterprise IT teams deep, end-to-end visibility across microservices, APIs, containers, databases, and legacy systems, without locking them into proprietary agents or limited in...

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effecti...

Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Leno...